OMC Financial Services LTD Sells 150 Shares of Zoetis Inc. $ZTS

OMC Financial Services LTD reduced its stake in Zoetis Inc. (NYSE:ZTS) by 3.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,790 shares of the company’s stock after selling 150 shares during the period. OMC Financial Services LTD’s holdings in Zoetis were worth $591,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Nova Wealth Management Inc. bought a new stake in shares of Zoetis during the first quarter worth about $25,000. 1248 Management LLC bought a new stake in shares of Zoetis during the first quarter worth about $27,000. Saudi Central Bank bought a new stake in shares of Zoetis during the first quarter worth about $29,000. Cornerstone Planning Group LLC increased its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after acquiring an additional 88 shares in the last quarter. Finally, REAP Financial Group LLC increased its position in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ZTS shares. Piper Sandler boosted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Leerink Partners downgraded shares of Zoetis from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. UBS Group decreased their target price on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating for the company in a research report on Monday. Leerink Partnrs downgraded shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Hold” and a consensus target price of $195.00.

Zoetis Stock Up 0.7%

Zoetis stock opened at $146.13 on Wednesday. The firm has a 50 day moving average price of $148.58 and a 200-day moving average price of $153.55. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $189.98. The company has a market capitalization of $64.76 billion, a P/E ratio of 25.15, a P/E/G ratio of 2.33 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the business earned $1.56 earnings per share. Zoetis’s revenue for the quarter was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. Zoetis’s dividend payout ratio is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.